WORCESTER, Mass., Oct. 14 /PRNewswire/ — Generex Biotechnology
Corporation (Nasdaq:
GNBT) (www.generex.com) advises its
stockholders that votes cast in respect of the reverse stock split
proposal put forward at the Annual Meeting of the Company’s
stockholders held on July 28, 2010 DO NOT COUNT as votes
cast in respect of the reverse stock split proposal being put
forward at the Special Meeting of stockholders scheduled for 10
a.m. EDT on Friday, October 15, 2010.  In order to vote in
respect of the current reverse stock split proposal, stockholders
must cast their votes using the proxy form issued for the Special
Meeting.

Stockholders whose stock is held on their behalf by brokerage
houses may not have received the proxy solicitation materials,
including proxy forms, in respect of the Special Meeting.
 Those stockholders are urged to contact their brokers or the
brokerage proxy department in order to vote their stock at the
Special Meeting.

Stockholders may also fax completed proxy forms for the Special
Meeting (with the control number(s) and both sides of the proxy
form) to Generex at 1-416-364-9363 up until 10 a.m. EDT
tomorrow.

Questions

Should stockholders have any questions regarding the proxy
voting procedures (including changing previously cast votes),
please contact Legend Securities, Inc. by telephone at 877-317-7526
or via email at
gnbtproxy@legendsecurities.com for US residents.
Non-US residents should contact Generex directly at 800-391-6755 or
contact their broker/dealer.

About Generex Biotechnology Corporation

Generex is engaged in the research, development, and
commercialization of drug delivery systems and technologies.
Generex has developed a proprietary platform technology for the
de

‘/>”/>

SOURCE